SAHA treatment led to the caspase-3 cleavage and activation of caspases 3/7 in NPC parental cells, which did not occur in NPC-tolerant cells (Figure 1D, Supplementary Figure 1A). Here, CASP3 is linked to nasopharyngeal carcinoma.